The National Immunisation Schedule is the series of vaccines that are offered free to babies, children, adolescents and adults.
The schedule of vaccines listed below applies from 1 October 2020.
*From 1 July to 30 September 2020 practices will continue to be supplied with the previously scheduled vaccine brands (Varilrix, ADT Booster) until these vaccine stocks are depleted.
Links in the table above provide more information about the diseases and the vaccines that prevent them.
Funded vaccines for high risk groups
Publicly funded hepatitis A, hepatitis B, haemophilus influenzae type b, human papillomavirus, influenza, meningococcal, pertussis (Tdap), pneumococcal, tuberculosis and varicella vaccines are available for children and adults at high risk of some diseases due to other medical conditions. For more details see the Additional Funded vaccines for special groups page of the Immunisation Handbook.
Meningococcal ACWY vaccine available to certain groups 1 December 2019
From 1 December 2019 the meningococcal ACWY vaccine (Menactra) is fully funded for individuals aged 13 to 25 years in close-living situations.
This means that one dose of meningococcal ACWY vaccine is funded for those aged 13 years to 24 years (under 25 years) who:
- are entering within the next three months, or are in their first year of living in boarding school hostels, tertiary education halls of residence, military barracks or prisons.
In addition, from 1 December 2019 to 30 November 2020 people already living in boarding school hostels, tertiary education halls of residence, military barracks or prisons will also have access to the vaccine.
It is important to note the ACWY vaccine does not provide protection against meningococcal B disease. As a result, it is important to consider meningococcal disease even in people who have been vaccinated if they present with symptoms consistent with meningococcal disease.
Immunisation programme decisions
For information about how New Zealand's National Immunisation Schedule is determined and administered, see immunisation programme decisions.